v3.25.2
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenues    
Total revenues $ 23,150 $ 21,890
Cost of revenues:    
Total cost of revenues 7,103 6,792
Gross profit 16,047 15,098
Operating expenses:    
Research and development (net of grant participations of $ 10 and $ 144 for the three months ended March 31, 2025, and 2024, respectively) 5,991 7,149
Sales and marketing 7,338 7,790
General and administrative 3,427 2,902
Total operating expenses 16,756 17,841
Operating loss (709) (2,743)
Financial income, net 673 540
Loss before income tax expense (36) (2,203)
Income tax expense 296 307
Net loss $ (332) $ (2,510)
Net loss per share:    
Basic (in Dollars per share) $ (0.01) $ (0.07)
Diluted (in Dollars per share) $ (0.01) $ (0.07)
Weighted average number of shares used in per share computations of net loss:    
Basic (in Shares) 39,620,521 38,411,724
Diluted (in Shares) 39,620,521 38,411,724
Unrealized loss on available-for-sale marketable securities $ (21) $ (13)
Total comprehensive loss from available-for-sale marketable securities (21) (13)
Unrealized loss on foreign currency cash flow hedges transactions (554) (234)
Net amount reclassified to earnings from hedging transactions (120) (122)
Total comprehensive loss from hedge transactions (674) (356)
Total other comprehensive loss (695) (369)
Total comprehensive loss (1,027) (2,879)
Products    
Revenues    
Total revenues 6,465 7,400
Cost of revenues:    
Total cost of revenues 3,317 3,013
Services    
Revenues    
Total revenues 16,685 14,490
Cost of revenues:    
Total cost of revenues $ 3,786 $ 3,779